Emergence and evolution of a prevalent new SARS-CoV-2 variant in the United States AA Pater, MS Bosmeny, CL Barkau, KN Ovington, R Chilamkurthy, ... BioRxiv, 2021.01. 11.426287, 2021 | 43 | 2021 |
High throughput nanopore sequencing of SARS-CoV-2 viral genomes from patient samples AA Pater, MS Bosmeny, AA White, RJ Sylvain, SB Eddington, ... Journal of biological methods 8 (COVID 19 Spec Iss), 2021 | 29 | 2021 |
Gene editing with CRISPR-Cas12a guides possessing ribose-modified pseudoknot handles EA Ageely, R Chilamkurthy, S Jana, L Abdullahu, D O’Reilly, PJ Jensik, ... Nature Communications 12 (1), 6591, 2021 | 13 | 2021 |
Emergence and evolution of a prevalent new SARS-CoV-2 variant in the United States. bioRxiv. 2021 AA Pater, MS Bosmeny, CL Barkau, KN Ovington, R Chilamkurthy, ... https://www. biorxiv. org/content/10.1101/2021.01 11, v2, 2021 | 5 | 2021 |
Efficient Cloning and Sequence Validation of Repetitive and High GC-Content Short Hairpin RNAs R Chilamkurthy, AA White, AA Pater, PJ Jensik, KT Gagnon Human gene therapy 33 (15-16), 829-839, 2022 | 2 | 2022 |
Sequencing-guided design of genetically encoded small RNAs targeting CAG repeats for selective inhibition of mutant huntingtin MA Parasrampuria, AA White, R Chilamkurthy, AA Pater, F El-Azzouzi, ... Molecular Therapy-Nucleic Acids 35 (2), 2024 | 1 | 2024 |
Binding to the conserved and stably folded guide RNA pseudoknot induces Cas12a conformational changes during ribonucleoprotein assembly S Sudhakar, CL Barkau, R Chilamkurthy, HM Barber, AA Pater, SD Moran, ... Journal of Biological Chemistry 299 (5), 2023 | 1 | 2023 |
Efficient Cloning and Sequence Validation of Repetitive and High GC-Content shRNAs. R Chilamkurthy, AA White, AA Pater, PJ Jensik, KT Gagnon Human Gene Therapy, 2022 | | 2022 |
CHARACTERIZATION OF DIVERSE NONCODING RNAS IN THERAPEUTICS, BIOTECHNOLOGY AND CHROMATIN BIOLOGY R Chilamkurthy | | |